BECLOMETASONE/FORMOTEROL/GLYCOPYRRONIUM VS. FIXED AND OPEN COMBINATIONS OF INHALED CORTICOSTEROIDS, LONG-ACTING B2-AGONIST, AND LONG-ACTING MUSCARINIC ANTAGONIST IN ADULTS WITH UNCONTROLLED ASTHMA: A NETWORK META-ANALYSIS

被引：0
|
作者：
Orlovic, M. [1 ]
Nikolaidis, G. [2 ]
Tzelis, D. [3 ]
Barouma, I [3 ]
Vele, A. [1 ]
Kots, M. [1 ]
van der Deijl, M. [1 ]
Madoni, A. [4 ]
机构：
[1] Chiesi Farmaceutici Spa, Parma, PR, Italy
[2] IQVIA, London, England
[3] IQVIA Ltd, Athens, Attica, Greece
[4] Chiesi Farmaceutici Spa, Parma, PR, Italy
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE556
引用
收藏
页码：S159 / S160
页数：2
相关论文
共 50 条
  • [31] Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting (32-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting (32-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study
    Wang, Meng-Ting
    Lai, Jyun-Heng
    Huang, Ya-Ling
    Liou, Jun-Ting
    Cheng, Shih-Hsuan
    Lin, Chen Wei
    Pan, Hsueh-Yi
    Hsu, Yu-Juei
    Tsai, Chen-Liang
    CHEST, 2021, 160 (04) : 1255 - 1270
  • [32] Are fixed combinations of inhaled corticosteroids and long-acting β2-agonists really harmless in asthmatics?
    Boussageon, R.
    Laforest, L.
    Van Ganse, E.
    REVUE DES MALADIES RESPIRATOIRES, 2012, 29 (09) : 1169 - 1170
  • [33] Comparative Effectiveness of Long-Acting Beta2-Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease
    Samp, Jennifer C.
    Joo, Min J.
    Schumock, Glen T.
    Calip, Gregory S.
    Pickard, A. Simon
    Lee, Todd A.
    PHARMACOTHERAPY, 2017, 37 (04): : 447 - 455
  • [34] CAPTAIN: Effects of Adding the Long-Acting Muscarinic Antagonist Umeclidinium to Inhaled Corticosteroid/Long-Acting Beta2-Agonist Therapy on Symptoms in Patients with Inadequately Controlled Asthma
    Gardiner, F.
    Pizzichini, E.
    Pavord, I
    Brusselle, G.
    Oppenheimer, J.
    Kerstjens, H.
    Papi, A.
    Inoue, H.
    Tabberer, M.
    Fowler, A.
    Slade, D.
    Bailes, Z.
    Barnes, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [35] Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma
    Kew, Kayleigh M.
    Dahri, Karen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [36] Long-acting β2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care
    Engelkes, Marjolein
    Janssens, Hettie
    de Jongste, Johan
    Sturkenboom, Miriam
    Verhamme, Katia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [37] Long-Acting β2 Agonist Without Concomitant Inhaled Corticosteroids in Children with Asthma in Primary Care
    Engelkes, Marjolein
    Janssens, Hettie M.
    de Jongste, Johan C.
    Sturkenboom, Miriam C. J. M.
    Verhamme, Katia M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 152 - 153
  • [38] Inhaled Corticosteroids or Long-Acting β-Agonists Alone or in Fixed-Dose Combinations in Asthma Treatment: A Systematic Review of Fluticasone/Budesonide and Formoterol/Salmeterol
    Frois, Christian
    Wu, Eric Q.
    Ray, Saurabh
    Colice, Gene L.
    CLINICAL THERAPEUTICS, 2009, 31 (12) : 2779 - 2803
  • [39] Comparison of vilanterol, a novel long-acting beta(2) agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
    Lotvall, Jan
    Bateman, Eric D.
    Busse, William W.
    O'Byrne, Paul M.
    Woodcock, Ashley
    Toler, William T.
    Jacques, Loretta
    Goldfrad, Caroline
    Bleecker, Eugene R.
    JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE, 2014, 13
  • [40] Cochrane Corner: Addition of Long-Acting Beta2 Agonists or Long-Acting Muscarinic Antagonists Versus Doubling the Dose of Inhaled Corticosteroids (ICS) in Adolescents and Adults With Uncontrolled Asthma With Medium-Dose ICS
    Baigel, Rachel
    Gregory, Ian
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (09): : 647 - 650
12345